West Pharmaceutical Services Total Assets 2010-2022 | WST

West Pharmaceutical Services total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • West Pharmaceutical Services total assets for the quarter ending March 31, 2022 were $3.295B, a 20.26% increase year-over-year.
  • West Pharmaceutical Services total assets for 2021 were $3.314B, a 18.61% increase from 2020.
  • West Pharmaceutical Services total assets for 2020 were $2.794B, a 19.32% increase from 2019.
  • West Pharmaceutical Services total assets for 2019 were $2.341B, a 18.32% increase from 2018.
West Pharmaceutical Services Annual Total Assets
(Millions of US $)
2021 $3,314
2020 $2,794
2019 $2,341
2018 $1,979
2017 $1,863
2016 $1,717
2015 $1,695
2014 $1,670
2013 $1,672
2012 $1,564
2011 $1,399
2010 $1,294
2009 $1,271
West Pharmaceutical Services Quarterly Total Assets
(Millions of US $)
2022-03-31 $3,295
2021-12-31 $3,314
2021-09-30 $3,143
2021-06-30 $2,934
2021-03-31 $2,740
2020-12-31 $2,794
2020-09-30 $2,583
2020-06-30 $2,392
2020-03-31 $2,247
2019-12-31 $2,341
2019-09-30 $2,174
2019-06-30 $2,123
2019-03-31 $2,036
2018-12-31 $1,979
2018-09-30 $1,946
2018-06-30 $1,874
2018-03-31 $1,870
2017-12-31 $1,863
2017-09-30 $1,930
2017-06-30 $1,843
2017-03-31 $1,734
2016-12-31 $1,717
2016-09-30 $1,735
2016-06-30 $1,705
2016-03-31 $1,668
2015-12-31 $1,695
2015-09-30 $1,667
2015-06-30 $1,664
2015-03-31 $1,596
2014-12-31 $1,670
2014-09-30 $1,673
2014-06-30 $1,705
2014-03-31 $1,708
2013-12-31 $1,672
2013-09-30 $1,665
2013-06-30 $1,613
2013-03-31 $1,577
2012-12-31 $1,564
2012-09-30 $1,527
2012-06-30 $1,463
2012-03-31 $1,457
2011-12-31 $1,399
2011-09-30 $1,398
2011-06-30 $1,415
2011-03-31 $1,366
2010-12-31 $1,294
2010-09-30 $1,300
2010-06-30 $1,222
2010-03-31 $1,254
2009-12-31 $1,271
2009-09-30 $1,264
2009-06-30 $1,218
2009-03-31 $1,142
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.141B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.140B 19.96
McKesson (MCK) United States $45.179B 13.28
AmerisourceBergen (ABC) United States $30.289B 13.97
Laboratory Of America Holdings (LH) United States $22.213B 9.28
Cooper (COO) United States $15.181B 23.36
Cardinal Health (CAH) United States $14.444B 11.09
CONMED (CNMD) United States $2.694B 27.82
Invacare (IVC) United States $0.053B 0.00